-
Wednesday, 03/21/2012
The group applied research in respiratory diseases, gets a big hit in the call 2012 of the European Respiratory Society (ERS) Fellowships
The IAMR group will host two ERS Fellowships and sent one of his pre-doctoral researchers, Joan Daniel Martí, to London also awarded with an ERS short term fellowship
Ernesto Crisafulli, Marta Francesca di Pasquale and Joan Daniel Martí have been selected to enjoy a short term fellowship that will allow them to stay a few months away from their home institution.
-
Thursday, 01/19/2012
IAMR group incorporates a pharmacist for the line of the animal model
She is joining the research team to conduct her doctoral thesis
The latest incorporation in our research group is Elisabet Aguilera Xiol, who has a Degree in Pharmacy at the University of Barcelona. Her role in our group will consist of helping in the animal experimental model line of research conducting her doctoral thesis in the field of microbiology.
-
Monday, 12/19/2011
IAMR group joins a doctor to investigate on alpha-1 antitrypsin deficiency
She comes from the University Sassari to gain experience in research
The latest incorporation at the research group is Barbara Piras, graduated in Medicine from the University of Sassari, in Sardinia. She is currently doing the residency in pneumology at the University of Sassari. Her role in the research team will be to participate in the research of alpha-1 antitrypsin research line.
-
Friday, 12/02/2011
Catia Cillóniz succesfully defended her doctoral thesis: Community-acquired pneumonia: A prospective study of etiology and clinical outcome over a period of 12 years of study
The public event was held last November 29th in the University of Barcelona, Faculty of Medicine
Catia Cillóniz is a biologist specialized in microbiology who is currently working in the Applied Research in Respiratory diseases group in IDIBAPS of Barcelona. During her doctoral thesis in Hospital Clinic, Dr. Cillóniz research focused on the etiology of community acquired pneumonia (CAP). Results were published in two journals of high impact factor: Thorax and Critical Care.The public event took place last November 29th in the University of Barcelona, Faculty of Medicine, Room 14, and the thesis tribunal comprised Dra. Rosario Menéndez, from Hospital La Fe in Valencia, Dr. Jordi Almirall, from Consorci Sanitari del Maresme and Dr. José Antonio Martínez, from Hospital Clinic of Barcelona.
-
Thursday, 11/10/2011
A study about IL-6 response during weaning associates increasing levels of this inflammatory biomarker with Spontaneous breathing trial failure in COPD patients.
The manuscript was published in the online version of European Respiratory Journal last July 20, 2011
Further studies may corroborate the different IL-6 responses among different populations who initiate weaning, and its potential clinical implications, but in the manuscript entitled: The effect of spontaneous breathing on systemic interleukin 6 during ventilator weaning, it is clear IL-6 increases during the Spontaneous breathing trial (SBT) and that this increase is more evident in COPD patients who fail the SBT
-
Friday, 11/04/2011
Elena Prina and Valeria Giunta presented their work at the IV CIBERES Training Meeting in Mallorca
Elena Prina presented a poster about Thrombocytosis as a Diagnostic and Prognostic Marker in Community Acquired Pneumonia and Valeria Giunta presented a poster about bacterial translocation into airways during mechanical ventilation
Both Research Physicians, Elena Prina and Valeria Giunta presented their work in a poster session at the IV CIBER Training Meeting on Respiratory Diseases that was held in Mallorca last 27-28th of October.
-
Monday, 10/17/2011
"Nosocomial Pneumonia and Ventilator-Associated Pneumonia"
European Respiratory Society Monograph, Vol. 53, 2011
Nosocomial pneumonia, and particularly ventilator-associated pneumonia (VAP), is the second most frequent intra-hospital infection. The incidence of VAP has decreased in the last 5 years, from 14 to 9–10 cases per 1,000 days of mechanical ventilation. This has been an important achievement but nosocomial pneumonia and VAP still carry very high rates of morbidity and mortality and high financial costs.
-
Wednesday, 10/05/2011
New data on aetiology and prognosis of Community acquired polymicrobial pneumonia in the ICU has been published in Critical Care Journal
This study has been carried on by Catia Cilloniz and its results will be part of her Doctoral thesis directed by Prof. Antoni Torres
Clinical implications of having polymicrobial community acquired pneumonia in patients admitted to the ICU have been poorly studied. In the manuscript entitled: Community acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis, authors have studied a population of 362 patients, of which 39 had polymicrobial infections mainly due to Streptococcus pneumoniae (n=28, 72%), respiratory viruses (n=15, 39%) and Pseudomonas aeruginosa (n=8, 21%).
-
Thursday, 09/22/2011
The Gravity-VAP trial obtained official endorsement by the European Critical Care Research Network (ECCRN) of the European Society of Intensive Care Medicine
Great advantages for the Gravity-VAP trial through the endorsement by the ECCRN of the ESICM
Early in September, the Gravity-VAP trial obtained official endorsement by the European Critical Care Research Network (ECCRN) of the European Society of Intensive Care Medicine. The endorsement will facilitate, integrate and support collaborations between institutions of the Gravity-VAP Network, ultimately resulting in improved and faster patient enrollment. Additionally, the endorsement will help to broaden the interest regarding the trial within the European Community.
-
Friday, 09/02/2011
The manuscript entitled “Predictors of prolonged weaning and survival during ventilator weaning in a respiratory ICU” appears in the Top 5 Articles of the Intensive Care Medicine
Below are the 5 most-read articles on the site. This list represents the readers' preference
Predictors of prolonged weaning and survival during ventilator weaning in a respiratory ICU
Jacobo Sellares, Miquel Ferrer, Esteban Cano, Hugo Loureiro, Mauricio Valencia, Antoni TorresRead another new about this manuscript
